$FOLD AMICUS THERAPEUTICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMICUS THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in AMICUS THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in AMICUS THERAPEUTICS INC for free.

CIK Number: 0001178879
IRS Number: 200422823
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FOLD
Company Address: 1 CEDAR BROOK DRIVE CRANBURY 08512
Phone number: 619-537-9849

Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Market Capitalization: $869.61M
Prev close: $6.02
Average Daily Volume: 3,723,300
Days Low: $5.82
Year Low: $4.41
Year High: $9.83

AMICUS THERAPEUTICS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Baird William D IIIChief Financial Officer127,622768,284shares bought: 149,475 / shares sold: -92,054 BUYOct 17 20181 month ago
Bleil Lynn DorseyDirector9,60057,792shares bought: 9,600 / shares sold: 0 BUYSep 11 20182 months ago
Clark David MichaelChief People Officer57,770347,775shares bought: 56,012 / shares sold: 0 BUYOct 11 20181 month ago
PERCEPTIVE ADVISORS LLC10% Owner20,694,424124,580,432shares bought: 3,147,477 / shares sold: -1,100,000 STRONG BUYOct 05 20181 month ago

View all AMICUS THERAPEUTICS INC insiders.

AMICUS THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 17 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...Option ExerciseM2.4510,00024,50024,000
Oct 17 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...SellS12.2310,000122,275117,622127.6 K to 117.6 K (-7.84 %)
Oct 17 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...BuyM2.4510,00024,500127,622117.6 K to 127.6 K (+8.50 %)
Oct 11 2018FOLDAMICUS THERAPEUTIC ...Clark David MichaelChief People Office ...Option ExerciseA12.8484,8421,089,37184,842
Oct 11 2018FOLDAMICUS THERAPEUTIC ...Clark David MichaelChief People Office ...GrantA0.0056,012057,7701.8 K to 57.8 K (+3,186.12 %)
Oct 05 2018FOLDAMICUS THERAPEUTIC ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP12.6930,000380,70020,724,42420.7 M to 20.7 M (+0.14 %)
Oct 05 2018FOLDAMICUS THERAPEUTIC ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP12.4520,000249,00020,694,42420.7 M to 20.7 M (+0.10 %)
Sep 25 2018FOLDAMICUS THERAPEUTIC ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP12.5350,000626,50020,674,42420.6 M to 20.7 M (+0.24 %)
Sep 17 2018FOLDAMICUS THERAPEUTIC ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP11.74100,0001,174,00020,624,42420.5 M to 20.6 M (+0.49 %)
Sep 14 2018FOLDAMICUS THERAPEUTIC ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP12.00500,0006,001,50020,524,42420 M to 20.5 M (+2.50 %)
Sep 11 2018FOLDAMICUS THERAPEUTIC ...Bleil Lynn DorseyDirectorOption ExerciseA12.5014,605182,56314,605
Sep 11 2018FOLDAMICUS THERAPEUTIC ...Bleil Lynn DorseyDirectorGrantA0.009,60009,6000 to 9.6 K
Jul 05 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...Option ExerciseM2.4510,00024,50034,000
Jul 05 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...SellS15.6310,000156,292107,622117.6 K to 107.6 K (-8.50 %)
Jul 05 2018FOLDAMICUS THERAPEUTIC ...Baird William D IIIChief Financial Off ...BuyM2.4510,00024,500117,622107.6 K to 117.6 K (+9.29 %)

View all AMICUS THERAPEUTICS INC insider transactions.